Study Summary
This trial will study whether modifying the default dose for high-risk drugs when prescribed electronically to hospitalized patients aged ≥65 years impacts prescribing behavior.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 7 Secondary · Reporting Duration: 30 days post-discharge regarding hospitalization during which a high-risk drug was prescribed
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Control
1 of 2
Intervention
1 of 2
Active Control
Experimental Treatment
8640 Total Participants · 2 Treatment Groups
Primary Treatment: EHR-based "nudge" interventions · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 65+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the cap on participants in this research endeavor?
"Yes, the information shared on clinicaltrials.gov affirms that recruitment for this research is ongoing. The trial first appeared online on February 16th 2022 and was most recently updated in April 6th 2022; it requires 8640 participants from 1 medical centre." - Anonymous Online Contributor
Are researchers still signing up participants for this study?
"The clinical trial database confirms that recruitment is ongoing for this medical trial. It was initially posted on February 16th 2022 and the last edit to it occured on April 6th, 2022." - Anonymous Online Contributor